Is there a BP benefit of changing the time of aspirin administration in treated hypertensive patients?

European Journal of Preventive Cardiology

Volumn 19, Issue 4, 2012, Pages 706-711

  Dimitrov, Yves ^a   Baguet, Jean Philippe ^b   Hottelart, Carine ^c   Marboeuf, Philippe ^d   Tartiere, Jean Michel ^e   Ducher, Michel ^f   Fauvel, Jean Pierre ^f  

^a Club des Jeunes Hypertensiologues   (France)

^b Club des Jeunes Hypertensiologues   (France)

^c Club des Jeunes Hypertensiologues   (France)

^d Club des Jeunes Hypertensiologues   (France)

^e Club des Jeunes Hypertensiologues   (France)

^f EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Ambulatory blood pressure monitoring; aspirin; hypertension

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DRUG EFFECT; EVENING DOSAGE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; PREVENTION STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TIME TO TREATMENT; ANALYSIS OF VARIANCE; CIRCADIAN RHYTHM; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG COMBINATION; FRANCE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; ASPIRIN; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FRANCE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84871688157     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/1741826711418165     Document Type: Article

References (33)

1. de Gaetano G. Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice. Lancet. 2001 ; 357: 89-95
2. The Medical Research Council's General Practice Research Framework. Lancet. 1998 ; 351: 233-241
3. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment. Lancet. 1998 ; 351: 1177-1184
4. Wilson SL, Poulter NR. The effect of non-steroidal anti-inflammatory drugs and other commonly used non-narcotic analgesics on blood pressure levels in adults. J Hypertension. 2006 ; 24: 1457-1469
5. Polonia J, Gama G, Camões I, Bernardo F, Andrade P, et al. Influence of nonsteroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients. J Hypertens. 1995 ; 13: 925-931
6. Nawarskas JJ, Cirigliano MD, Spinler SA. Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan. Am J Hypertens. 1999 ; 12: 784-789
7. Avanzini F, Palumbo G, Alli C, Roncaglioni MC, Ronchi E, Cristofari M, et al. Effects of low-dose aspirin on clinic and ambulatory blood-pressure in treated hypertensive patients. Am J Hypertens. 2000 ; 13: 611-616
8. Smith SR, Coffman TM, Svetkey LP. Effect of low-dose aspirin on thromboxane production and the antihypertensive effect of captopril. J Am Soc Nephrol. 1993 ; 4: 1133-1139
9. Magagna A, Abdel-Haq B, Favilla S, Taddei S, Salvetti A. Hemodynamic and humoral effects of low-dose aspirin in treated and untreated essential hypertensive patients. Blood Press. 1994 ; 3: 236-241
10. Zanchetti A, Hansson L, Leonetti G, Rahn KH, Ruilope L, Warnold G, et al. Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy. J Hypertens. 2002 ; 20: 1015-1022
11. Hermida RC, Ayala DE, Iglesias M, Mojón A, Silva I, Ucieda R, et al. Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women. Hypertension. 1997 ; 30: 589-595
12. Hermida RC, Ayala DE, Fernández JR, Mojón A, Alonso I, Silva I, et al. Administration time-dependant effects of aspirin in women at differing risk for preeclampsia. Hypertension. 1999 ; 34: 1016-1023
13. Hermida RC, Ayala DE, Iglesias M. Administration time-dependent influence of aspirin on blood pressure in pregnant women. Hypertension. 2003 ; 41: 651-656
14. Hermida RC, Ayala DE, Iglesias M, Halberg F. Time-dependent effects of ASA administration on blood pressure in healthy subjects. Chronobiologica. 1994 ; 21: 201-213
15. Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, et al. Administration time-dependent effects of aspirin on blood pressure in untreated hypertensive patients. Hypertension. 2003 ; 41: 1259-1267
16. Hermida RC, Ayala DE, Mojon A, Iglesias M. Influence of aspirin usage on blood pressure: dose and administration-time dependencies. Chronobiol Int. 1997 ; 14: 619-637
17. Hermida RC, Calvo C, Lopez JE. Aspirin administered at bedtime, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients. J Am Coll Cardiol. 2005 ; 46: 975-983
18. Hermida RC, Calvo C, Ayala JE, Mojón A, Rodríguez M, Chayán L, et al. Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives. Hypertension. 2005 ; 46: 1060-1068
19. Messerli FH. Aspirin: A novel antihypertensive drug? Or two birds with one stone?. J Am Coll Cardiol. 2005 ; 46 (6). 984-985
20. Bautista LE, Vera LM. Antihypertensive effects of aspirin: what is the evidence?. Curr Hypertens Rep. 2010 ; 12 (4). 282-289
21. Mansoor GA, White WB. Contribution of ambulatory blood pressure monitoring to the design and analysis of antihypertensive therapy trials. J Cardiovasc Risk. 1994 ; 1: 136-142
22. Ying Z, Giachini FR, Tostes RC, Webb RC. Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation. Cardiovasc Res. 2009 ; 83: 155-162
23. Husain S, Mulcahy D, Panza JA, Quyyumi AA. Aspirin improves endothelial dysfunction in atherosclerosis. Circulation. 1998 ; 97: 716-720
24. Noon JP, Hand MF, Webb DJ. Impairement of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin. Cardiovasc Res. 1998 ; 38: 480-484
25. Monobe H, Nakamura K, Ohe T. Effects of low-dose aspirin on endothelial function in hypertensive patients. Clin Cardiol. 2001 ; 24: 705-709
26. Kodama M, Yamasaki Y, Sakamoto K, Yoshioka R, Matsuhisa M, Kajimoto Y, et al. Antiplatelet drugs attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes. Thromb Res. 2000 ; 97: 239-245
27. Taubert D, Berkels R, Grosser N, Schröder H, Gründemann D, Schömig E. Aspirin induces nitric oxide release from vascular endothelium: A novel mechanism of action. Br J Pharmacol. 2004 ; 143: 159-165
28. Nye EJ, Hockings GI, Grice JE, Torpy DJ, Walters MM, Crosbie GV, et al. Aspirin inhibits vasopressin-induced hypothalamic-pituitary-adrenal activity in normal humans. J Clin Endocrinol Metab. 1997 ; 82: 812-817
29. Wang JL, Harris RC. Cycloxygenase-2 inibition decreases renin content and lower blood pressure in a model of renovascular hypertension. Hypertension. 1999 ; 34: 96-101
30. Wu R, De Champlain J. Antioxidative properties of acetylsalicylic Acid on vascular tissues from normotensive and spontaneously hypertensive rats. Circulation. 2002 ; 105: 387-392
31. Wu R, De Champlain J. Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats. J Hypertension. 2004 ; 22: 681-682
32. Hermida RC, Mojon A, Fernandez JR. Ambulatory blood pressure control with bedtime administration in subjects with prehypertension. Am J Hypertens. 2009 ; 22: 896-903
33. Snoep JD, Hovens MM, Pasha SM, Frölich M, Pijl H, Tamsma JT, et al. Time-dependent effects of low-dose aspirin on plasma renin activity, aldosterone, cortisol, and catecholamines. Hypertension. 2009 ; 54: 1136-1142